A randomized, phase 3, open-label study to evaluate SGN-B6A compared with docetaxel in adult subjects with previously treated non-small cell lung cancer

  • Moore, Maggie (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date4/12/24 → 3/12/26

Keywords

  • Clinical Trials
  • SGNB6A-002